MED vs AMZN

For growth investors, Amazon.

com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus -36. 0% for Medifast, Inc. (MED). Amazon. com, Inc. (AMZN) offers the better valuation at 38. 3x trailing P/E (35. 3x forward), making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Amazon.

com, Inc. (AMZN) delivered a total return of +66. 3%, compared to -89. 3% for Medifast, Inc. (MED). Over 10 years, the gap is even starker: AMZN returned +715. 9% versus MED's +25. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Medifast, Inc.

(MED) is the lower-risk stock at 0. 94β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 61% more volatile than MED relative to the S&P 500. On balance sheet safety, Medifast, Inc. (MED) carries a lower debt/equity ratio of 8% versus 37% for Amazon. com, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Amazon.

com, Inc. (AMZN) is pulling ahead at 12. 4% versus -36. 0% for Medifast, Inc. (MED). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to -994. 7% for Medifast, Inc.. Over a 3-year CAGR, AMZN leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Amazon.

com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus -4. 8% for Medifast, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus -3. 7% for MED. At the gross margin level — before operating expenses — MED leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for AMZN: 11.

6% to $306. 77.

In this comparison, MED (0.

1% yield) pays a dividend. AMZN does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Medifast, Inc.

(MED) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MED: +25. 3%, AMZN: +715. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.